Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Daltonics Reports Spike in Revenue, Rising Profits for Q1 2001

NEW YORK, May 7 – Bruker Daltonics reported strong revenue growth for the first quarter of 2001, with revenue jumping to $21.7 million from $14 million in the comparable quarter a year ago.

The company classified 70 percent of its revenue from life science products, 8 percent from substance detection products, and 22 percent from aftermarket products.

Bruker Daltonics of Billerica, Mass., spent $4.6 million on research and development during the first quarter of 2001, compared with $3.6 million in the year-ago quarter. Selling, general, and administrative costs also increased to $6.2 million from $3.7 in the first quarter of 2000.

The company’s net profits rose to $1 million, or 2 cents per share, from $100,000, or zero cents a share, in the year ago peirod. Wall Street analysts predicted earnings of 1 cent a share, according to a poll of five brokers conducted by First Call/Thomson Financial. 

Contrary to other life science research equipment manufacturers, such as Applied Biosystems, Bruker Daltonics has not revised its earnings estimates for the year, and continues to expect to see 25 to 30 percent top-line sales growth.

"As we had announced already in early April 2001, our new order bookings for life science systems remain robust,” Frank Laukien, CEO of Bruker Daltonics, said in a statement. “While we are aware of concerns about slowing growth in our field, our product lines, including our new products introduced recently at PittCon, continue to be very well received by customers." 

Bruker Daltonics manufactures MALDI-TOF, ESI-TOF, ion trap, and FTMS mass spectrometers, as well as analysis software.  
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.